 |
|
|
Peter Rudd, MD
Profile: http://med.stanford.edu/profiles/Peter_Rudd/
Contact: Academic Appointments
Appointment
Organization
Professor - Med Center Line
|
Curriculum Vitae PDF
Honors & Awards
Title
Organization
Date(s)
Phi Beta Kappa
Amherst College
1966
Diplomate
National Board of Medical Examiners
1971
Diplomate
American Board of Internal Medicine
1975
Fellowship
W.K. Kellogg Foundation; Hospital Research and Education Trust
1977
Fellowship
Andrew W. Mellon Foundation
1977-81
8 honors and awards: view full list
Administrative Appointments
Title
Organization
Start Year
End Year
Member
SHC Quality Improvement and Patient Safety Committee
2003
-
Chair
Clinical Science Affinity Group; School of Medicine Curricular Reform Project
2002
2003
Member
Medical Center Quality Assurance Reorganization Committee
2002
2002
Senator-At Large
Stanford University School of Medicine Faculty Senate
2002
-
Member
Stanford Hospital & Clinics Care Review Committee
1998
-
7 appointments: view full list
Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation
BA
Amherst College
French
1966
MD
Case Western Reserve University
Medicine
1970
Internship
Stanford Univ. Affil. Hospitals
Internal Medicine
1971
Residency
Stanford Univ. Affil. Hospitals
Internal Medicine
1975
Fellowship
RWJ Clinical Scholars; McGill
Health care planning
1976
Web Site Links
Research/Lab website:
Personal Web site
Research Interests
Quality improvement (QI) efforts seek to make medical care the “best it can be” rather than merely “good enough” to avoid censure. Focus on improving the average performance usually produces more net benefit than eliminating outliers, often by simplification, standardization, and specification. We have worked with electronic medication monitors, clinical databases, and computerized physician order entry systems for better clinical outcomes. We have also developed training modules for students, house officers, and clinicians for enhanced professionalism and accountability.
Recent work has emphasized optimizing among cost, quality and access, using examples of common internal medicine problems (e.g., community acquired pneumonia, diabetes mellitus, blood product transfusion). QI project teams arose in both inpatient and outpatient settings. The optimal results occur from combining didactic training and practical applications via projects with plan-do-study-act rapid cycles of change. We have also examined the relative impact of patient versus physician behaviors as well as system factors in determining clinical outcomes for control of elevated cholesterol.
In prior work, we explored medication adherence. Medication-taking represents a complex behavior integral to optimal outcomes in much of ambulatory medical care. We have helped develop and test electronic medication monitors capable of dynamic tracking of medication dispensing events over time. The technology offers a time-based matrix by which to interpret, understand, and improve clinical outcomes that depend on patients' medication-taking behavior.
Using the electronic monitor technology, we have studied
a) Normative patterns of medication-taking among subgroups of patients on chronic cardiovascular medications
b) Dose-response relationships among established and investigational antihypertensive medications for misinterpretations of optimal dosing recommendations
c) Critical evaluation of reported adverse drug reactions, based on dosing errors that involve omission, commission, or misscheduling
d) Clinical protocols useful for assessing apparent secondary resistance to treatment after initial clinical responsiveness
e) Cost-effectiveness of the incremental information about precise medication-taking events, patterns, and distortions.
Recent work has emphasized optimizing among cost, quality and access, using examples of common internal medicine problems (e.g., community acquired pneumonia, diabetes mellitus, blood product transfusion). QI project teams arose in both inpatient and outpatient settings. The optimal results occur from combining didactic training and practical applications via projects with plan-do-study-act rapid cycles of change. We have also examined the relative impact of patient versus physician behaviors as well as system factors in determining clinical outcomes for control of elevated cholesterol.
In prior work, we explored medication adherence. Medication-taking represents a complex behavior integral to optimal outcomes in much of ambulatory medical care. We have helped develop and test electronic medication monitors capable of dynamic tracking of medication dispensing events over time. The technology offers a time-based matrix by which to interpret, understand, and improve clinical outcomes that depend on patients' medication-taking behavior.
Using the electronic monitor technology, we have studied
a) Normative patterns of medication-taking among subgroups of patients on chronic cardiovascular medications
b) Dose-response relationships among established and investigational antihypertensive medications for misinterpretations of optimal dosing recommendations
c) Critical evaluation of reported adverse drug reactions, based on dosing errors that involve omission, commission, or misscheduling
d) Clinical protocols useful for assessing apparent secondary resistance to treatment after initial clinical responsiveness
e) Cost-effectiveness of the incremental information about precise medication-taking events, patterns, and distortions.
Publications
- Rudd P, "Diuretics were superior to calcium-channel blockers and short-term ACE inhibitors for reducing heart failure in hypertension." ACP J Club 2007 Jan-Feb; 146: 1: 16 More »
- Rudd P, "Diuretics were superior to calcium channel blockers and short term ACE inhibitors for reducing heart failure in hypertension." Evid Based Med 2007; 12: 1: 17 More »
- Rudd P, "Review: beta-blockers are less effective than other antihypertensive drugs for reducing risk for stroke in primary hypertension." ACP J Club 2006 May-Jun; 144: 3: 67 More »
- Rudd P, "Review: Beta blockers are less effective than other antihypertensive drugs for reducing risk of stroke in primary hypertension." Evid Based Med 2006; 11: 3: 85 More »
- Rudd P, Houston Miller N, Kaufman J, Kraemer HC, Bandura A, Greenwald G, DeBusk, RF "Nurse care management for hypertension: A systems approach" American Journal of Hypertension 2004; 17: 10: 921-7 More »
50 publications: view full list
